With a growing list of regulatory approvals sparking sustained interest in producing monoclonal antibodies, Eppendorf has been supporting researchers who are working with both bacterial and ...

Monoclonal antibodies are novel therapeutic agents ... difficulties since duration and severity of disease, concomitant medications and illnesses, dates of studies performed, inclusion/exclusion ...

Monoclonal antibodies offer a major advantage in drug discovery, and it’s no longer difficult to quickly make a lot of new antibodies. But this leads to their biggest drawback. Screening and ...

Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for ...

‘Mono’ means one and 'clone' means identical copy. Monoclonal antibodies are, therefore, identical copies of one type of antibody. Antibodies bind to specific antigens on pathogens. This means ...

FMC63, an IgG2a mouse monoclonal antibody, targets CD19. To date, a majority of the reported CART19 trials include the anti-CD19 scFv extracted from FMC63, such as both the FDA-approved CARs ...

With over 80 publications, Mohta has expertise in the use of biological drugs for both cutaneous and systemic disorders. View Full Profile. Learn about our Editorial Policies. Scientists create ...

Monoclonal antibodies (mAbs) have emerged as important therapeutics for the treatment of life-threatening diseases. The successes of mAbs have triggered the development of various next generation ...